Position paper on the use of COVID-19 convalescent plasma: an update
Blood Transfus
.
2021 Jul;19(4):277-280.
doi: 10.2450/2021.0150-21.
Epub 2021 May 21.
Authors
Daniele Prati
1
,
Francesco Fiorin
2
,
Pierluigi Berti
3
,
Giustina De Silvestro
4
,
Patrizia Accorsi
5
,
Angelo Ostuni
6
;
Italian Society for Transfusion Medicine and Immunohaematology (SIMTI), and the Italian Society for Haemapheresis and Cell Manipulation (SIdEM)
Affiliations
1
Department of Transfusion Medicine and Haematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
2
Department of Transfusion Medicine, ULSS 8 Berica, Vicenza, Italy.
3
Immunohaematology and Transfusion Medicine, "Umberto Parini" Hospital, Aosta, Italy.
4
Blood Transfusion Service, University Hospital of Padua, Padua, Italy.
5
Department of Haematology, Transfusion Medicine and Biotechnologies, "S. Spirito" Hospital, Pescara, Italy.
6
Transfusion Medicine Unit, University-Hospital Policlinico, Bari, Italy.
PMID:
34059190
PMCID:
PMC8297677
DOI:
10.2450/2021.0150-21
No abstract available
MeSH terms
COVID-19 / blood
COVID-19 / therapy*
COVID-19 Serotherapy
Consensus*
Humans
Immunization, Passive / standards
Inpatients
Italy
Meta-Analysis as Topic
Randomized Controlled Trials as Topic
Treatment Outcome